Show simple item record

dc.contributor.authorGiampaolo, S
dc.contributor.authorChiarolla, CM
dc.contributor.authorKnöpper, K
dc.contributor.authorVaeth, M
dc.contributor.authorKlein, M
dc.contributor.authorMuhammad, A
dc.contributor.authorBopp, T
dc.contributor.authorBerberich-Siebelt, F
dc.contributor.authorPatra, AK
dc.contributor.authorSerfling, E
dc.contributor.authorKlein-Hessling, S
dc.date.accessioned2023-04-03T11:00:21Z
dc.date.available2023-04-03T11:00:21Z
dc.date.issued2023-03-17
dc.identifier.issn2589-0042
dc.identifier.issn2589-0042
dc.identifier.other106234
dc.identifier.urihttps://pearl.plymouth.ac.uk/handle/10026.1/20652
dc.description.abstract

In thymus, the ablation of T cell receptor (TCR)-activated transcription factor NFATc1 or its inducible isoforms during the double-negative (DN) stages of thymocyte development leads to a marked increase in γδ thymocytes whereas the development of αβ thymocytes remains mostly unaffected. These γδ thymocytes are characterized by the upregulation of the promyelocytic leukemia zinc-finger factor (PLZF), the "master regulator" of natural killer T (NKT) cell development, and the acquisition of an NKT γδ cell phenotype with higher cell survival rates. The suppressive function of NFATc1 in NKT γδ cell formation critically depends on the remote enhancer E2, which is essential for the inducible expression of NFATc1 directed by its distal promoter P1. Thus, the enhancer deciphers a strong γδ TCR signal into the expression of inducible NFATc1 isoforms resulting in high levels of NFATc1 protein that are essential to control the numbers of NKT γδ cells.

dc.format.extent106234-106234
dc.format.mediumElectronic-eCollection
dc.languageen
dc.publisherCell Press
dc.subjectImmunology
dc.subjectdevelopmental biology
dc.subjectmolecular biology
dc.titleNFATc1 induction by an intronic enhancer restricts NKT γδ cell formation
dc.typejournal-article
dc.typeJournal Article
plymouth.author-urlhttps://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000996440100001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=11bb513d99f797142bcfeffcc58ea008
plymouth.issue3
plymouth.volume26
plymouth.publication-statusPublished
plymouth.journaliScience
dc.identifier.doi10.1016/j.isci.2023.106234
plymouth.organisational-group|Plymouth
plymouth.organisational-group|Plymouth|Faculty of Health
plymouth.organisational-group|Plymouth|REF 2021 Researchers by UoA
plymouth.organisational-group|Plymouth|Users by role
plymouth.organisational-group|Plymouth|Users by role|Academics
plymouth.organisational-group|Plymouth|REF 2021 Researchers by UoA|UoA01 Clinical Medicine
plymouth.organisational-group|Plymouth|Faculty of Health|Peninsula Medical School
dc.publisher.placeUnited States
dcterms.dateAccepted2023-02-13
dc.date.updated2023-04-03T11:00:06Z
dc.rights.embargodate2023-4-4
dc.identifier.eissn2589-0042
dc.rights.embargoperiodforever
rioxxterms.versionofrecord10.1016/j.isci.2023.106234


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record


All items in PEARL are protected by copyright law.
Author manuscripts deposited to comply with open access mandates are made available in accordance with publisher policies. Please cite only the published version using the details provided on the item record or document. In the absence of an open licence (e.g. Creative Commons), permissions for further reuse of content should be sought from the publisher or author.
Theme by 
Atmire NV